NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

High Content Screening Assay for Cell Viability (EUNCL-GTA-020)   Add to my SOP compendium

BRD ID: 2,432

Source: EUNCL Tier: SOP Number of times downloaded: 1916

Description

This document describes procedures for culturing the A431 epidermoid carcinoma cell line and x-based cytotoxicity testing in response to nanoparticle exposure using the High Content Screening (HCS) platform by automated imaging and subsequent multiparametric image analysis. This SOP is a product of the European Nanomedicine Characterisation Laboratory (EUNCL) and is available from https://www.euncl.org/. THE URL SPECIFIED IS A LEGACY WEBSITE. NCI IS NO LONGER IN CONTACT WITH THE SOURCE THAT CONTRIBUTED THIS SOP.

Documents for Download

EUNCL_GTA_020.pdf [Size: 498 KB]

Biospecimens
  • Cell - Skin
Diagnoses
  • General
Topics
  • Biospecimen Processing
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...